AptarGroup CEO Stephan Tanda to retire Sept 1, 2026; Gael Touya appointed successor

APTARGROUP, INC.

CEO Tanda to retire effective Sep 1, 2026; will serve as strategic advisor through Dec 31, 2026 and remain on Board until year-end.
Gael Touya, currently president of Aptar Pharma, named President & CEO effective Sep 1, 2026; also to join Board.
Touya employment agreement: base salary $1,060,000, target bonus 120%, LTI target 500% of base salary; €2.5M deferred compensation payout.
Retention equity awards: CFO Vanessa Kanu receives $1.3M in RSUs (3-year cliff); Closures president Hedi Tlili receives $1.3M (2-year cliff).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.